December 2023
1. BELGA S, Hussain S, Avery RK, Nauroz Z, et al
   Impact of recipient age on mortality among CMV-seronegative lung transplant recipients with CMV-seropositive donors.
   J Heart Lung Transplant. 2023 Dec 5:S1053-2498(23)02143.
   

   >> Share

   
   October 2023
2. GONDI KT, Kaul DR, Gregg KS, Golbus JR, et al
   Cytomegalovirus Infection is Associated with Impaired Myocardial Flow Reserve After Heart Transplantation.
   J Heart Lung Transplant. 2023 Oct 7:S1053-2498(23)02063.
   

   >> Share

   
   March 2023
3. RIDDELL P, Juvet SC
   Natural killer cells, CMV infection, and antibody-mediated rejection.
   J Heart Lung Transplant. 2023;42:315-316.
   

   >> Share

   
   October 2022
4. VIETZEN H, Jaksch P, Puchhammer-Stockl E
   The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients.
   J Heart Lung Transplant. 2022 Oct 21. pii: S1053-2498(22)02184.
   

   >> Share

   
   May 2022
5. GARDINER BJ, Lee SJ, Robertson AN, Cristiano Y, et al
   Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients.
   J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01943.
   

   >> Share

   
   December 2021
6. SAULLO JL, Baker AW, Snyder LD, Reynolds JM, et al
   Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis.
   J Heart Lung Transplant. 2021 Dec 22. pii: S1053-2498(21)02626.
   

   >> Share

   
   
7. GAO Q, Hartwig MG, Todd JL
   Bridging the translation gap in cytomegalovirus therapeutics through ex vivo lung perfusion: Opportunities and challenges.
   J Heart Lung Transplant. 2021 Dec 5. pii: S1053-2498(21)02615.
   

   >> Share

   
   October 2021
8. RIBEIRO RVP, Ku T, Wang A, Pires L, et al
   Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin.
   J Heart Lung Transplant. 2021 Oct 25. pii: S1053-2498(21)02544.
   

   >> Share

   
   June 2021
9. ORESCHAK K, Saba LM, Rafaels N, Ambardekar AV, et al
   Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
   J Heart Lung Transplant. 2021 Jun 12. pii: S1053-2498(21)02342.
   

   >> Share

   
   May 2021
10. VIETZEN H, Hartenberger S, Jaksch P, Puchhammer-Stockl E, et al
    Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    J Heart Lung Transplant. 2021 May 31. pii: S1053-2498(21)02324.
    

    >> Share

    
    November 2020
11. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    

    >> Share

    
    January 2019
12. MOAYEDI Y, Gomez CA, Fan CPS, Miller RJH, et al
    Infectious complications after heart transplantation in patients screened with gene expression profiling.
    J Heart Lung Transplant. 2019 Jan 7. pii: S1053-2498(19)30006.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share